TRIFAROTENE (Aklief®)

Clinical Indication

Cutaneous treatment of Acne Vulgaris

Date of classification

September 2022

Grey

Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.